Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950123-06-004971
Filing Date
2006-04-21
Accepted
2006-04-21 17:01:42
Documents
3
Effectiveness Date
2006-04-21

Document Format Files

Seq Description Document Type Size
1 FORM 8-K y20092e8vk.htm DEFA14A 11701
2 EX-99.1: PRESS RELEASE y20092exv99w1.htm EX-99.1 11828
3 GRAPHIC y20092y2009201.gif GRAPHIC 3820
  Complete submission text file 0000950123-06-004971.txt   30431
Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-15190 | Film No.: 06773290
SIC: 2835 In Vitro & In Vivo Diagnostic Substances